Get started
Author

Jinwang Wei

MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway
2013 · Xin Yang, Lei Liang, et al. · Hepatology · 288
PDF
Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma
2018 · Xiaomei Gao, Yuanyuan Sheng, et al. · Journal of Experimental & Clinical Cancer Research · 74
PDF
Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity
2018 · Zhen-Hao Liu, Bao-Feng Lian, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 74
PDF
Osteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentin
2016 · Qiongzhu Dong, Xuchao Zhu, et al. · Oncotarget · 73
PDF
Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer
2019 · Yuan‐sheng Zang, Chun Dai, et al. · Cancer Medicine · 65
PDF
Osteopontin promotes metastasis of intrahepatic cholangiocarcinoma through recruiting MAPK1 and mediating Ser675 phosphorylation of β-Catenin
2018 · Yan Zheng, Chuang Zhou, et al. · Cell Death and Disease · 62
PDF
MicroRNA-29a-5p Is a Novel Predictor for Early Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma after Surgical Resection
2012 · Hai-Tao Zhu, Qiong-Zhu Dong, et al. · PLoS ONE · 57
PDF
β-catenin mutation is correlated with a favorable prognosis in patients with hepatocellular carcinoma
2015 · ZHENG WANG, YUAN-YUAN SHENG, et al. · Molecular and Clinical Oncology · 51
PDF
Interleukin-6 enhances cancer stemness and promotes metastasis of hepatocellular carcinoma via up-regulating osteopontin expression.
2016 · Chao-Qun Wang, Hao-Ting Sun, et al. · PubMed Central · 48
Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors
2020 · Jiaping Li, Wei Jiang, et al. · Journal of Translational Medicine · 41
PDF
Distinct microbes, metabolites, and the host genome define the multi-omics profiles in right-sided and left-sided colon cancer
2024 · Lei Liang, Cheng Kong, et al. · Microbiome · 37
PDF
Mutated EPHA2 is a target for combating lymphatic metastasis in intrahepatic cholangiocarcinoma
2018 · Yuanyuan Sheng, Jinwang Wei, et al. · International Journal of Cancer · 30
PDF
MicroRNA-219-5p Promotes Tumor Growth and Metastasis of Hepatocellular Carcinoma by Regulating Cadherin 1
2018 · Jing Yang, Yuan-Yuan Sheng, et al. · BioMed Research International · 29
PDF
Comprehensive multi‐omics analysis of resectable locally advanced gastric cancer: Assessing response to neoadjuvant camrelizumab and chemotherapy in a single‐center, open‐label, single‐arm phase II trial
2024 · Yuzhou Zhao, Danyang Li, et al. · Clinical and Translational Medicine · 23
RNA-seq based elucidation of mechanism underlying the protective effect of Huangshui polysaccharide on intestinal barrier injury in Caco-2 cells
2022 · Jiaying Huo, Mei Li, et al. · Food Research International · 22
Estimating tumor mutational burden across multiple cancer types using whole-exome sequencing
2021 · Chuang Zhou, Song Chen, et al. · Annals of Translational Medicine · 21
PDF
Association of Specific Genotypes in Metastatic Suppressor HTPAP with Tumor Metastasis and Clinical Prognosis in Hepatocellular Carcinoma
2011 · Ning Ren, Jin-Cai Wu, et al. · Cancer Research · 20
Genome-Wide Association Study Identifies a Genetic Prediction Model for Postoperative Survival in Patients with Hepatocellular Carcinoma
2019 · Jinwang Wei, Yuanyuan Sheng, et al. · Medical Science Monitor · 18
PDF
Unique genomic features and prognostic value of COSMIC mutational signature 4 in lung adenocarcinoma and lung squamous cell carcinoma
2020 · Xiuyu Cai, Zhenghe Chen, et al. · Annals of Translational Medicine · 10
PDF
Development of a genome atlas for discriminating benign, preinvasive, and invasive lung nodules
2024 · Peng Liang, Minhua Peng, et al. · MedComm · 8
PDF
An open, observational, three-arm clinical study of 2–3 cycles of treatment as neoadjuvant therapy in operable locally advanced non-small cell lung cancer: An interim analysis
2022 · Linping Gu, Xue Wang, et al. · Frontiers in Immunology · 7
PDF
Using Clinical Genomic Sequencing to Guide Personalized Cancer Therapy in China
2019 · Yuxian Bai, Guan Wang, et al. · Personalized Medicine · 4
Study of the interaction mechanisms of ellagitannins from Phyllanthus emblica L. with acetylcholinesterase using multi-spectroscopy, molecular docking, and molecular dynamic
2025 · Yangzom Dawa, Jin-Wang Wei, et al. · Journal of Molecular Structure · 1
Correction: Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+/CD44 + cancer stem cells to 5 azacytidine in hepatocellular carcinoma
2023 · Xiaomei Gao, Yuanyuan Sheng, et al. · Journal of Experimental & Clinical Cancer Research · 1
PDF
Data from Association of Specific Genotypes in Metastatic Suppressor HTPAP with Tumor Metastasis and Clinical Prognosis in Hepatocellular Carcinoma
2023 · Ning Ren, Jin-Cai Wu, et al.
Works count: 45
Citation count: 1,064
H-index: 18
I10-index: 19
Year
Topic
Type